261 related articles for article (PubMed ID: 31649873)
1. ACAT1 and Metabolism-Related Pathways Are Essential for the Progression of Clear Cell Renal Cell Carcinoma (ccRCC), as Determined by Co-expression Network Analysis.
Chen L; Peng T; Luo Y; Zhou F; Wang G; Qian K; Xiao Y; Wang X
Front Oncol; 2019; 9():957. PubMed ID: 31649873
[TBL] [Abstract][Full Text] [Related]
2. Identification of Biomarkers Associated With Pathological Stage and Prognosis of Clear Cell Renal Cell Carcinoma by Co-expression Network Analysis.
Chen L; Yuan L; Qian K; Qian G; Zhu Y; Wu CL; Dan HC; Xiao Y; Wang X
Front Physiol; 2018; 9():399. PubMed ID: 29720944
[TBL] [Abstract][Full Text] [Related]
3. Co-Expression Network Analysis Identified LTF in Association with Metastasis Risk and Prognosis in Clear Cell Renal Cell Carcinoma.
Ni L; Yuan C; Zhang C; Xiang Y; Wu J; Wang X; Wu X
Onco Targets Ther; 2020; 13():6975-6986. PubMed ID: 32764988
[TBL] [Abstract][Full Text] [Related]
4. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma.
Chen L; Yuan L; Wang Y; Wang G; Zhu Y; Cao R; Qian G; Xie C; Liu X; Xiao Y; Wang X
Int J Biol Sci; 2017; 13(11):1361-1372. PubMed ID: 29209141
[TBL] [Abstract][Full Text] [Related]
5. Identification of
Yang H; Wang Y; Zhang Z; Li H
Front Genet; 2020; 11():905. PubMed ID: 32973873
[TBL] [Abstract][Full Text] [Related]
6. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
[TBL] [Abstract][Full Text] [Related]
7. Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC).
Yuan L; Chen L; Qian K; Qian G; Wu CL; Wang X; Xiao Y
Genom Data; 2017 Dec; 14():132-140. PubMed ID: 29159069
[TBL] [Abstract][Full Text] [Related]
8. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
[TBL] [Abstract][Full Text] [Related]
9. Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets.
Naghdibadi M; Momeni M; Yavari P; Gholaminejad A; Roointan A
Kidney Blood Press Res; 2023; 48(1):135-150. PubMed ID: 36854280
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
11. Three novel hub genes and their clinical significance in clear cell renal cell carcinoma.
Xiao H; Chen P; Zeng G; Xu D; Wang X; Zhang X
J Cancer; 2019; 10(27):6779-6791. PubMed ID: 31839812
[No Abstract] [Full Text] [Related]
12. Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis.
Yuan L; Zeng G; Chen L; Wang G; Wang X; Cao X; Lu M; Liu X; Qian G; Xiao Y; Wang X
Int J Biol Sci; 2018; 14(3):266-279. PubMed ID: 29559845
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma.
Zhang X; Wang Z; Zeng Z; Shen N; Wang B; Zhang Y; Shen H; Lu W; Wei R; Ma W; Wang C
Cancer Cell Int; 2021 Apr; 21(1):222. PubMed ID: 33865387
[TBL] [Abstract][Full Text] [Related]
14. Identifying a Novel Biomarker
Xiong Y; Yuan L; Chen L; Zhu Y; Zhang S; Liu X; Xiao Y; Wang X
J Cancer; 2018; 9(21):3912-3922. PubMed ID: 30410595
[TBL] [Abstract][Full Text] [Related]
15. Co-expression Network Analysis Identifies Fourteen Hub Genes Associated with Prognosis in Clear Cell Renal Cell Carcinoma.
Chen JY; Sun Y; Qiao N; Ge YY; Li JH; Lin Y; Yao SL
Curr Med Sci; 2020 Aug; 40(4):773-785. PubMed ID: 32862390
[TBL] [Abstract][Full Text] [Related]
16. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
Peng Y; Greenland NY; Lang UE; Stohr BA
Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma.
Zhang H; Zou J; Yin Y; Zhang B; Hu Y; Wang J; Mu H
PeerJ; 2019; 7():e8096. PubMed ID: 31788359
[TBL] [Abstract][Full Text] [Related]
18. Expression of gasdermin D in clear cell renal cell carcinoma and its effect on its biological function.
Zhang J; Wang Y; Ma J; Aimudula A
Front Oncol; 2023; 13():1163714. PubMed ID: 37483501
[TBL] [Abstract][Full Text] [Related]
19. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.
Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J
Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501
[TBL] [Abstract][Full Text] [Related]
20. Identification of Hub Genes Associated With Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis.
Huang H; Zhu L; Huang C; Dong Y; Fan L; Tao L; Peng Z; Xiang R
Front Oncol; 2021; 11():726655. PubMed ID: 34660292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]